Lucid Diagnostics Inc.
- Last sale
- Nov 12, 2026 · +7.83%
- Market cap
- $86.41M
- 206.98M shares
- Filings
- 283
Q3 2026+8.3% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2025N/M FY24 yoy
Q3 2025+18.3% FY24 yoy
- $86.41M
- —
- 15.9×
- 14.6×
- -59.98%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $4,706,000 | reported | |
| FY 2024 | 2024-12-31 | $4,346,000 | reported | |
| FY 2023 | 2023-12-31 | $2,428,000 | reported | |
| FY 2022 | 2022-12-31 | $377,000 | reported | |
| FY 2021 | 2021-12-31 | $500,000 | reported |
Surgical & medical instruments & apparatus
Lucid Diagnostics Inc. is the 94th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
XAIRBeyond Air, Inc.$7.7M107.3%433.0%$3.7MIVFINVO Fertility, Inc.$6.8M4.3%340.9%$3.2MPMIPicard Medical, Inc.$4.9M12.5%546.6%$21.8M
LUCDLucid Diagnostics Inc. (this company)$4.7M8.3%1,232.7%$86.4M
INBSIntelligent Bio Solutions Inc.$4.2M38.1%294.9%$6.4MTNONTenon Medical, Inc.$3.9M20.4%318.4%$4.8MICCMIceCure Medical Ltd.$3.4M2.7%445.6%$51.9MAURXNuo Therapeutics, Inc.$3.3M142.7%75.8%$63.1MOSRHOSR Health, Inc.$2.9M17.7%931.2%$7.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Lucid Diagnostics Inc. · CIK 1799011 · Engraved from SEC EDGAR